CS logo
small CS logo
The Third Affiliated Hospital of Harbin Medical University ( Site 3302)

Harbin, Heilongjiang, China

About The Third Affiliated Hospital of Harbin Medical University ( Site 3302)


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at The Third Affiliated Hospital of Harbin Medical University ( Site 3302)


During the past decade, The Third Affiliated Hospital of Harbin Medical University ( Site 3302) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "The Third Affiliated Hospital of Harbin Medical University ( Site 3302)" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at The Third Affiliated Hospital of Harbin Medical University ( Site 3302)


According to Clinical.Site data, the most researched conditions in "The Third Affiliated Hospital of Harbin Medical University ( Site 3302)" are "Head and Neck Squamous Cell Carcinoma" (2 trials). Many other conditions were trialed in "The Third Affiliated Hospital of Harbin Medical University ( Site 3302)" in a lesser frequency.

Clinical Trials Intervention Types at The Third Affiliated Hospital of Harbin Medical University ( Site 3302)


Most popular intervention types in "The Third Affiliated Hospital of Harbin Medical University ( Site 3302)" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Lenvatinib" (2 trials), "Pembrolizumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at The Third Affiliated Hospital of Harbin Medical University ( Site 3302)


The vast majority of trials in "The Third Affiliated Hospital of Harbin Medical University ( Site 3302)" are 2 trials for "All" genders.

Clinical Trials Status at The Third Affiliated Hospital of Harbin Medical University ( Site 3302)


Currently, there are NaN active trials in "The Third Affiliated Hospital of Harbin Medical University ( Site 3302)". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in The Third Affiliated Hospital of Harbin Medical University ( Site 3302), undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Third Affiliated Hospital of Harbin Medical University ( Site 3302), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".